Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

Inherited High HDL Cholesterol, Blood Pressure May Play Role in AD Pathogenesis
News
Inherited High HDL Cholesterol, Blood Pressure May Play Role in AD Pathogenesis
05/23/2023
Genetically determined high systolic blood pressure and high-density lipoprotein (HDL) cholesterol were associated with increased odds of Alzheimer disease (AD) in a large genetic association study, according to study results published online...
Genetically determined high systolic blood pressure and high-density lipoprotein (HDL) cholesterol were associated with increased odds of Alzheimer disease (AD) in a large genetic association study, according to study results published online...
Genetically determined high...
05/23/2023
Psych Congress Network

Advertisement

A glass jug pours water into a drinking glass
News
Higher Parkinson Disease Risk in Veterans Exposed to Contaminated Water
05/22/2023
Exposure to the liquid chemical trichloroethylene (TCE) may increase the risk of Parkinson disease by as much as 70%, according to study results published in JAMA Neurology.
Exposure to the liquid chemical trichloroethylene (TCE) may increase the risk of Parkinson disease by as much as 70%, according to study results published in JAMA Neurology.
Exposure to the liquid chemical...
05/22/2023
Neurology
Insomnia
APA Conference News
Major Depressive Disorder With Insomnia Presents Treatment Goal Challenges
05/22/2023
Insomnia is associated with higher use of antidepressants, particularly those with sedative effects, according to a poster presented at this week’s APA annual meeting.
Insomnia is associated with higher use of antidepressants, particularly those with sedative effects, according to a poster presented at this week’s APA annual meeting.
Insomnia is associated with...
05/22/2023
Psych Congress Network
Clinician examining brain scans
News
Study Clarifies Connection Between Alzheimer Disease and Iron Redox
05/19/2023
Researchers from The University of Texas at Austin and the University of Illinois at Urbana-Champaign found an association between iron redox and Alzheimer disease in the brains of mice.
Researchers from The University of Texas at Austin and the University of Illinois at Urbana-Champaign found an association between iron redox and Alzheimer disease in the brains of mice.
Researchers from The University...
05/19/2023
Neurology

Advertisement

A hand chooses a happy face with a neutral and unhappy face next to them
News
ALS Patients Evaluate Facial Expressions Differently, Even Without Cognitive Impairment
05/18/2023
Patients with amyotrophic lateral sclerosis (ALS) exhibit different gaze patterns when visually scanning human facial expressions compared to healthy controls, according to new study findings.
Patients with amyotrophic lateral sclerosis (ALS) exhibit different gaze patterns when visually scanning human facial expressions compared to healthy controls, according to new study findings.
Patients with amyotrophic...
05/18/2023
Neurology
Lab culture research is conducted using a petri dish
News
Parkinson Disease Cells Show Poor Ability to Form Nerve Extensions in Lab Setting
05/15/2023
Nerve cells developed from the stem cells of people with Parkinson disease had significantly less ability to form the extensions necessary to create connections and transfer dopamine from one nerve cell to another.
Nerve cells developed from the stem cells of people with Parkinson disease had significantly less ability to form the extensions necessary to create connections and transfer dopamine from one nerve cell to another.
Nerve cells developed from the...
05/15/2023
Neurology
Alzheimer and cognitive decline
News
Positive Antibody Tests for Common Infections Associated With Reduced Cognition in Older Adults
05/12/2023
A greater number of positive antibody tests for common infections, including EBV, is associated with worse cognitive performance in older adults, a recent study found.
A greater number of positive antibody tests for common infections, including EBV, is associated with worse cognitive performance in older adults, a recent study found.
A greater number of positive...
05/12/2023
Psych Congress Network

Advertisement

FDA approval stamp
News
FDA Approves First Pharmacological Treatment for Dementia-Related Agitation
05/11/2023
The FDA has approved the sNDA of REXULTI® (brexpiprazole) for the treatment of agitation associated with dementia related to Alzheimer disease.
The FDA has approved the sNDA of REXULTI® (brexpiprazole) for the treatment of agitation associated with dementia related to Alzheimer disease.
The FDA has approved the sNDA of...
05/11/2023
Psych Congress Network
Neurosurgeons working
News
Minimally Invasive Neurosurgery Approach Could Assist Maximal, Safe Brain Tumor Resection
05/09/2023
Researchers have found a new minimally invasive approach (MIA) that could help to achieve maximal safe resection of brain tumors in eloquent areas and limit vision and hearing loss following surgery.
Researchers have found a new minimally invasive approach (MIA) that could help to achieve maximal safe resection of brain tumors in eloquent areas and limit vision and hearing loss following surgery.
Researchers have found a new...
05/09/2023
Neurology
Doctor examining a CT scan
News
Older Age Linked With Lower Risk of MS Activity After Stopping DMT
05/08/2023
A patient’s age at discontinuation of first-line disease-modifying therapy (DMT) was a significant predictor of the return of inflammatory disease activity and relapse among patients with multiple sclerosis (MS), according to study results...
A patient’s age at discontinuation of first-line disease-modifying therapy (DMT) was a significant predictor of the return of inflammatory disease activity and relapse among patients with multiple sclerosis (MS), according to study results...
A patient’s age at...
05/08/2023
Neurology

Advertisement

Advertisement

Advertisement

News

Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
News
Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
11/05/2024
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes...
11/05/2024
Psych Congress Network
Alone or Together, CBT and Modafinil Improve MS-Related Fatigue
News
Alone or Together, CBT and Modafinil Improve MS-Related Fatigue
11/01/2024
The wake-promoting drug modafinil, CBT, and a combination of both were associated with comparable, significant improvement in fatigue at 12 weeks in patients with MS and problematic fatigue.
The wake-promoting drug modafinil, CBT, and a combination of both were associated with comparable, significant improvement in fatigue at 12 weeks in patients with MS and problematic fatigue.
The wake-promoting drug...
11/01/2024
Neurology
Gene therapy
News
Concerns Linger After Gene Therapy Shows Long-Term Benefit for Cerebral Adrenoleukodystrophy
10/28/2024
Elivaldogene autotemcel (eli-cel) gene therapy for cerebral adrenoleukodystrophy (CALD) helped patients maintain neurological function, but also my have caused hematologic malignancies in some patients.
Elivaldogene autotemcel (eli-cel) gene therapy for cerebral adrenoleukodystrophy (CALD) helped patients maintain neurological function, but also my have caused hematologic malignancies in some patients.
Elivaldogene autotemcel...
10/28/2024
Neurology
Patient with family
News
During Recovery, Stroke Patients Benefit from Supportive Social Networks
10/24/2024
Large networks of family and friends are beneficial for blood pressure improvement among patients who experienced a stroke, according to a study published online in the International Journal of Cerebrovascular Disease and Stroke. “In aging...
Large networks of family and friends are beneficial for blood pressure improvement among patients who experienced a stroke, according to a study published online in the International Journal of Cerebrovascular Disease and Stroke. “In aging...
Large networks of family and...
10/24/2024
Neurology
International Stroke Burden Saw Hike Over Last 30 Years
News
International Stroke Burden Saw Hike Over Last 30 Years
10/22/2024
International stroke burden has increased from 1990 to 2021, according to recent findings from a global burden of disease (GBD) study published in The Lancet Neurology.
International stroke burden has increased from 1990 to 2021, according to recent findings from a global burden of disease (GBD) study published in The Lancet Neurology.
International stroke burden has...
10/22/2024
Neurology
Hands holding a head in profile with an illustrated heart over brain
News
Antiseizure Meds May Increase Cardiovascular Risk in Older Adults With Epilepsy
10/21/2024
A lifetime history of epilepsy is associated with new-onset cardiovascular events in older adults, according to study results published in JAMA Neurology.
A lifetime history of epilepsy is associated with new-onset cardiovascular events in older adults, according to study results published in JAMA Neurology.
A lifetime history of epilepsy...
10/21/2024
Neurology
FDA approval stamp
News
FDA Approves Infusion Treatment for Advanced Parkinson Disease in Adults
10/18/2024
AbbVie’s VYALEV (foscarbidopa and foslevodopa), the first 24-hour continuous subcutaneous infusion of levodopa-based therapy for managing motor fluctuations in adults with advanced Parkinson disease (PD), approved by the FDA.
AbbVie’s VYALEV (foscarbidopa and foslevodopa), the first 24-hour continuous subcutaneous infusion of levodopa-based therapy for managing motor fluctuations in adults with advanced Parkinson disease (PD), approved by the FDA.
AbbVie’s VYALEV (foscarbidopa...
10/18/2024
Neurology
Investigational Drug Improves Motor Function in Patients With SMA
News
Investigational Drug Improves Motor Function in Patients With SMA
10/16/2024
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational...
10/16/2024
Neurology
Tolebrutinib Delays Disability Progression in Nonrelapsing Secondary Progressive MS
News
Tolebrutinib Delays Disability Progression in Nonrelapsing Secondary Progressive MS
10/15/2024
Tolebrutinib delayed the time to onset of 6-month confirmed disability progression compared with placebo in patients with nonrelapsing secondary progressive MS, according to results presented at the European Committee for Treatment and...
Tolebrutinib delayed the time to onset of 6-month confirmed disability progression compared with placebo in patients with nonrelapsing secondary progressive MS, according to results presented at the European Committee for Treatment and...
Tolebrutinib delayed the time to...
10/15/2024
Neurology
An orange prescription container with generic pills spilling out in front of it
News
Masked Taper Plus CBT for Insomnia Effective in Benzodiazepine Discontinuation
10/10/2024
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
A masked drug taper combined...
10/10/2024
Psych Congress Network

Advertisement

Advertisement

Alzheimer's Disease CME Series

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/12/2020
Neurology
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology
11/12/2020
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease...
11/12/2020
Neurology
Claim-Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early...
11/12/2020
Neurology
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
11/10/2020
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations...
11/10/2020
Neurology

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use